| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |